|
Dear Colleagues,
We are delighted to invite you to an exclusive FREE live webinar on advances in care of locally advanced rectal cancer, hosted by GenesisCare, the UK’s leading independent specialist cancer care provider, in collaboration with the International Society of University Colon and Rectal Surgeons (ISUCRS).
This CPD-accredited session will bring together three internationally recognised experts whose work is helping to shape the future of gastrointestinal oncology.
Register today for this webinar and join our international experts as they explore the latest evidence and innovations, re-examining the management of locally advanced rectal cancer through the lenses of prediction, personalisation, and organ-preservation strategies to optimise patient-centred outcomes.
📅 Date: Wednesday, 14 January
🔬 Why Attend?
✅ Gain insights from world-renowned specialists ✅ Learn about innovative, evidence-based organ preservation strategies ✅ Engage in dynamic discussions and live Q&A
Whether you work in oncology, radiology, surgery, or cancer research, this webinar offers valuable insights into evolving organ-preserving strategies and their clinical impact.
Agenda
Convenor: Dr Kasia Owczarczyk, Consultant Clinical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Moderators: Dr Kasia Owczarczyk & Mr Joseph Nunoo-Mensah, Consultant Colorectal Surgeon, King’s College Hospital NHS Foundation Trust, London, UK
|
Attendance awards 1 RCR-accredited CPD point.
Dr. Hyun Kim is an internationally recognized thought leader in GI cancer, with special interest in adaptive radiation therapy and radiopharmaceuticals. He is the Principal Investigator of the NOM ERA (Nonoperative Management and Early Response Assessment in Rectal Cancer) trial, evaluating short course radiation and ctDNA in organ preservation, with initial results presented in ASTRO 2025.
Dr Kasia Owczarczyk has completed postdoctoral fellowship in Cancer Imaging Department at Kings College London. She published work on predictive biomarkers in anorectal radiotherapy and the role of radiomics in GI malignancies. She is part of the MR Linac advisory group at GenesisCare UK and has been the clinical lead for development of MR guided dose escalated short course rectal radiotherapy protocol.
Dr Svetlana Balyasnikova has a strong research interest in rectal cancer imaging, in particular in improving precision target volume delineation and MR guided rectal cancer radiotherapy. She completed a PhD research fellowship in advanced rectal cancer imaging with Professor Gina Brown at the Royal Marsden Hospital.
We look forward to seeing you there!
Kind regards,
Dr Kasia Owczarczyk, Consultant Clinical Oncologist, Guy’s and St Thomas’ NHS Hospital
Mr Adam Henderson, Market Development Manager, GenesisCare
Mr Joseph W Nunoo-Mensah, Immediate Past President, ISUCRS & Consultant Colorectal Surgeon, King’s College Hospital NHS Foundation Trust,
